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Abstract
Background: Dietary restriction (DR), a reduction in food intake without malnutrition, increases most aspects of
health during aging and extends lifespan in diverse species, including rodents. However, the mechanisms by which
DR interacts with the aging process to improve health in old age are poorly understood. DNA methylation could
play an important role in mediating the effects of DR because it is sensitive to the effects of nutrition and can
affect gene expression memory over time.
Results: Here, we profile genome-wide changes in DNA methylation, gene expression and lipidomics in response
to DR and aging in female mouse liver. DR is generally strongly protective against age-related changes in DNA
methylation. During aging with DR, DNA methylation becomes targeted to gene bodies and is associated with
reduced gene expression, particularly of genes involved in lipid metabolism. The lipid profile of the livers of DR
mice is correspondingly shifted towards lowered triglyceride content and shorter chain length of triglyceride-
associated fatty acids, and these effects become more pronounced with age.
Conclusions: Our results indicate that DR remodels genome-wide patterns of DNA methylation so that age-related
changes are profoundly delayed, while changes at loci involved in lipid metabolism affect gene expression and the
resulting lipid profile.
Background
Increasing frailty as result of declining organismal
function characterizes aging, which is also the major
risk factor for prevalent diseases of older people such
as diabetes, cancer and neurodegenerative disorders
[1, 2]. Environmental and genetic interventions can
ameliorate the effects of aging, with nutrition,
nutrient-sensing signaling networks and metabolism
playing evolutionarily conserved roles [1, 3–5]. Diet-
ary restriction (DR), in which food intake is reduced
while avoiding malnutrition, extends lifespan in di-
verse model and non-model organisms [3, 6]. DR
induces a remarkably broad-spectrum improvement in
health and resistance to aging-related diseases in both
rodents [3, 5] and rhesus monkeys [7]. In humans,
too, short-term DR increases multiple markers of
metabolic and cardiovascular health [8].
Experiments in laboratory model organisms have
indicated that the somatotropic axis [9] and nutrient-
sensing insulin/insulin-like growth factor/mTOR net-
work mediate at least part of the increased health from
DR [10–12]. Mediators such as altered proteostasis
[13], mitochondrial activity [14] and various forms of
stress resistance [15] may also be important. However,
the precise mechanisms mediating the effects of DR
remain elusive [1, 5, 6, 16] and are likely to be time-
dependent [16, 17]. DR induces major and tissue-
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specific changes in gene expression [18–20], and these
have implicated shifts in energy homeostasis, mitochon-
drial function and lipid metabolism [16, 17, 21–23] as
important processes induced by DR to improve health
during ageing. Lipid and fatty acid metabolism are
emerging as particularly central candidates, as these
were commonly identified in two large-scale meta-
analyses of more than 30 transcriptome datasets of
independent DR experiments and originating from
various tissues [18, 19]. DR-induced activation of trigly-
ceride synthesis and breakdown has also been observed
in Drosophila melanogaster, and these processes have
been shown experimentally to be essential for full
lifespan extension [24].
Epigenetic modifications are important regulators of
transcriptional networks, and are labile to both aging
and dietary interventions. DNA methylation occurs
primarily in the CpG dinucleotide and is a conserved
and somatically heritable mark that is generally associated
with transcriptional repression [25–27]. Age-associated
changes of methylation include both hyper- and hypome-
thylation at specific genomic locations that differ between
tissues [28, 29]. This age-related “epigenetic drift” has
been described as decreasing methylation across the gen-
ome, accompanied by locally restricted hypermethylation,
predominantly occurring within promoter regions and/or
CpG islands (CGIs) [25, 29–33]. In contrast, other studies
have reported global age-related hypermethylation in
human skin and murine hematopoietic stem cells
[34–36]. A recent analysis of high-throughput methy-
lation data identified a set of age-sensitive DNA
methylation sites in humans that together strongly
predict chronological age (“epigenetic clock”) [37, 38],
but that are also sensitive to ethnicity [39], biological
age [38], and infectious and other diseases [40, 41].
Dietary interventions, including starvation and protein
deprivation, can also alter patterns of DNA methyla-
tion, potentially in a long-lasting manner [42, 43],
including transgenerationally [26, 44].
Dietary, genetic and pharmacological interventions
that improve health during aging and extend lifespan
induce long-lasting changes in gene expression that
mediate their effects. Here we have asked if and how
age-related DNA methylation, transcription and lipid
composition dynamics of mouse liver are affected by
DR. We have carried out systematic profiling of
methylation by whole genome bisulfite sequencing
(BS-seq), of the transcriptome by RNA sequencing
(RNA-seq) and of lipid composition by lipidomics in
aging mouse cohorts with ad libitum (AL) and DR feeding.
Our work uncovers a general protective function of DR
against age-related methylation changes, together
with epigenetic reprogramming of lipid metabolism
genes.
Results
Dietary restriction transcriptionally regulates enzymes
involved in DNA methylation
To investigate the effects of age and DR on gene ex-
pression and DNA methylation, we used females of
the long-lived F1 hybrid mouse strain (C3B6F1), which
responds to DR with a robust increase in lifespan [3]. To
avoid effects on postnatal development, DR treatment was
started in 12-week-old animals, restricting DR mice to
40% of the food intake of AL controls. The DR mice
showed a 30% increase in median lifespan (Additional
file 1: Figure S1A) with a reduced body weight com-
pared to AL animals (Additional file 1: Figure S1B),
consistent with previous observations [3, 5], thereby
demonstrating the effectiveness of our DR regime.
We collected liver samples from AL and DR animals at
5 months (young) and 26 months (old), and used RNA-
seq to profile genome-wide transcriptional changes. We
identified 4232 and 4418 differentially expressed genes
(DEGs) between AL and DR in young and old animals,
respectively, with 3005 DEGs in common (Fig. 1a, b), a
highly significant overlap between young and old animals.
DR-induced gene expression changes of selected candi-
date genes were validated by quantitative real-time poly-
merase chain reaction (qRT-PCR) on an independent set
of mice (Additional file 1: Figure S2). Functional enrich-
ment and clustering analysis for the overlapping DEGs
highlighted fatty acid oxidation and lipid synthesis, insulin
signaling and glucose homeostasis, protein catabolism,
unfolded protein response, ribosome biogenesis, and
xenobiotic metabolism (Fig. 1c; Additional file 2: Table S1),
consistent with results of a meta-analysis of DR-induced
expression changes in liver [18, 19]. The largest cluster
contained genes involved in the regulation of gene expres-
sion, including Dnmt3b, which codes for one of the key
enzymes involved in de novo DNA methylation (Fig. 1d)
[45]. Additionally, Tet2 and Tet3, which catalyze oxidation
of 5-methylcytosine to 5-hydroxymethylcytosine and sub-
sequent demethylation [45], were differentially regulated
(Fig. 1d). DR may hence shape the DNA methylation
landscape.
DR protects from age-related changes in DNA methylation
We next asked whether DR affects the changes in DNA
methylation that normally occur during aging. We pro-
filed DNA methylation by genome-wide BS-seq of liver
samples from young and old AL and DR mice. We
focused our analysis on CpG methylation because levels
of non-CpG methylation are extremely low in liver. The
mammalian genome has local biases in CpG content
[46, 47] and analyses of fixed-length DNA windows, or
even predefined genomic regions, suffer from uneven
data density, and therefore risk biasing detection of
differences in methylation toward regions of high CpG
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density. We therefore made an unbiased comparison
using a conservative quantification approach similar to
[48] (summarized in Additional file 1: Figure S3A–D, for
details see “Methods”), with a sliding, binning approach,
with each bin covering 50 CpGs, and overlapping adja-
cent bins by 25 CpGs (Additional file 1: Figure S3A–C).
This approach resulted in a set of 1,167,959 bins cover-
ing 29 million CpGs. For each bin we calculated a single
methylation value averaged across CpGs ranging from
0% (no methylation) to 100%, (complete methylation).
Genomic elements such as genes, promoters and CGIs
were then mapped to bins. Median bin size was around
3500 bp (Additional file 1: Figure S3E), and we were able
to detect well-established features such as low methyla-
tion in bins overlapping promoter CGIs compared to
intragenic CGIs (Additional file 1: Figure S3F) [49, 50].
As expected, we found high levels of methylation
genome-wide, with most bins having levels in the
range of 70–95% (Fig. 2a). There were only subtle
changes in global methylation with age or DR. In
contrast to previously described age-related loss of
DNA methylation [25], we observed a mild increase
in global methylation with age (Fig. 2a), consistent
with other recent genome-wide studies [34–36]. Al-
though global changes were small, 3176 bins showed
a significant methylation difference (adjusted p < 0.05,
Chi-squared test; minimal required difference cutoff
of 10%). Of these age-related differentially methylated re-
gions (DMRs), 1945 gained and 1231 lost methylation
(Fig. 2b), consistent with the small increase in global
methylation with age. We next mapped age-related DMRs
to gene bodies and identified 241 genes associated with
Fig. 1 Transcriptome response to dietary restriction (DR) in the mouse liver. a, b Venn diagrams depicting the overlap of significantly upregulated (a)
and downregulated (b) genes under DR relative to the ad libitum-fed (AL) control group at young and old age. *** p < 0.001, one-sided Fisher’s exact
test. c Network representation of enriched gene ontology terms and pathways for genes differentially regulated under DR at both ages. Each node
(circles) represents one term/pathway. Edges (lines) connect terms with similar gene sets (distance stands in inverse relationship with overlap); further
functional clustering (color) was based on kappa statistics. Shown are representative terms per cluster. d MA-plots representing log2-transformed ratios
of gene expression levels under DR and AL at both ages versus average expression on a logarithmic scale. Genes showing differential expression
between the diets at both ages are marked in red (n = 3005). DNA de/methylation genes are highlighted
Hahn et al. Genome Biology  (2017) 18:56 Page 3 of 18
hypomethylated (Additional file 3: Table S2) and 275 with
hypermethylated DMRs (Additional file 4: Table S3).
Among these, we identified several hypermethylated
DMRs mapping to the body of the Elovl2 gene. Hyperme-
thylation of Elovl2 is associated with aging in humans and
mice [51–54]. Age-related hypermethylated genes showed
functional enrichment for regulation of transcription,
circadian rhythm, regulation of ERK and Ras signaling,
and response to growth factor signaling (Fig. 2c;
Additional file 5: Table S4). In contrast, age-related hypo-
methylated genes were involved in regulating the MAPK
cascade, xenobiotic metabolism, and amino acid and lipid
metabolism (Fig. 2c; Additional file 6: Table S5). Age-
related changes in methylation were of moderate magni-
tude, in the range of 10–35% (Fig. 2d), consistent with
previous studies [34–36].
In contrast to the 3176 age-related DMRs in AL
animals, we identified only 2250 in DR animals, with 1512
hypermethylated and 738 hypomethylated with age
(Fig. 2b). This lower number of age-related changes could
indicate that DR retards age-related methylation changes.
The null hypothesis is that the methylomes of DR and AL
animals age at the same rate. We therefore took an un-
biased approach, by comparing for each bin the difference
in methylation between AL and DR at old age against the
age-related change that occurred either under AL or DR
(Fig. 3a, b). In striking contrast to the null model, there
was a marked increase in scattering of bins during aging
under DR conditions (Fig. 3b), caused by bins that showed
age-related methylation differences in both conditions but
with a greater magnitude in AL animals. The significantly
decreased correlation and shallower slope of the relation-
ship in the DR animals further confirmed this observation
(Fig. 3a, b). To rule out any artifacts, we used permutation
analysis of (1) treatment labels per bin, (2) across age
within the same diet and (3) across diets within the same
age (Additional file 1: Figure S4; for details see
“Methods”), and the resulting distributions were clearly
distinct from the data (Additional file 1: Figure S4). Thus,
our analysis revealed global amelioration of age-related
DMRs by DR. To characterize DMRs in which age-related
changes were retarded by DR we used a statistical cutoff
Fig. 2 DNA methylation changes in the aging mouse liver. a Beanplot
representation of global DNA methylation levels in the liver of young
and old ad libitum-fed (AL) and dietary restriction (DR) mice
(n = 1,167,959 bins). Solid lines represent group-wise means;
density curves were scaled. b Number of significantly differentially
methylated regions (DMRs) (p < 0.05, ±10%<DNA methylation
difference) between young and old mice under AL and DR conditions.
c Functional enrichment of age-related differentially hyper- and
hypomethylated genes. d Density scatter plot of age-related DMRs
indicating the magnitude of DNA methylation changes with respect
to the methylation level in young AL mice. Lines indicate median of
methylation levels for hypo- and hypermethylated DMRs
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(Fig. 3a) to define 571 DMRs (Fig. 3b). Of these, 439 were
hypomethylated and 132 hypermethylated with age. Bean-
plot representation of the data confirmed that the methy-
lation of these DMRs changed with age in a diet-specific
manner (Fig. 3c). DR-ameliorated age-related DMRs
showed functional enrichment for genes involved in the
regulation of transcription and in ketone, acetyl-CoA and
long-chain fatty acid metabolism (Fig. 3d; Additional
file 7: Table S6; Additional file 8: Table S7), with fewer
genes affected than in the age-comparable dataset
(Fig. 2c). DR thus retarded age-related changes in DNA
methylation in specific functional categories of genes.
Fig. 3 Dietary restriction (DR) attenuated age-related changes in DNA methylation. a, b Scatterplot comparison of bin-wise differences between diets at
old age and age-related changes under ad libitum (AL) (a) and DR (b) conditions. Data density (red) is indicated on the axes. Blue line represents the linear
regression line. Dashed lines mark the two standard deviations (2*σ) cutoff (±9.68% methylation difference). Formulas for linear regression and Pearson
correlation coefficients are indicated. c Beanplot representation of methylation levels of 439 hypomethylated (left panel) and 132 hypermethylated
(right panel) age-related differentially methylated regions (DMRs) ameliorated by DR in young and old mouse livers. Solid lines represent group-wise
means; density curves are scaled. d Gene ontology and reactome enrichment of genes with age-related DMRs ameliorated by DR
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Aging leads to demethylation of active regulatory regions
and hypermethylation in repressed chromatin
We next asked whether age-related methylation changes
correlated with chromatin state, as previously reported
[55, 56]. We used publicly available histone modification
chromatin immunoprecipitation sequencing (ChIP-seq)
peaks from the ENCODE project, generated from the
liver of 8-week-old male C57BL/6 mice [57]. Interest-
ingly, age-related DMRs including the DR-ameliorated
DMRs were strongly enriched for open chromatin histone
marks, such as H3K9ac, H3K4me1 and H3K27ac [25, 27]
(Additional file 1: Figure S5A), and this enrichment was
more pronounced for age-related hypomethylated DMRs.
Age-related hypomethylated DMRs were strongly en-
riched for distal and intragenic active enhancers and active
promoters (Additional file 1: Figure S5B). Using the
Cistrome platform [58, 59] we detected strong enrichment
of age-related hypomethylated DMRs for a wide range of
binding sites of DNA-binding proteins, most of which
were transcription factors (Additional file 1: Figure S5C,
D). Hence, age-related DMRs and particularly hypomethy-
lated ones were strongly enriched in euchromatic regions
of the genome, suggesting a role of chromatin accessibility
in the methylation dynamics.
Bivalent chromatin domains are characterized by both
activating H3K4me3 and repressive H3K27me3 modifi-
cations, and have been associated with age-related
hypermethylation in humans and mice [33, 60]. We used
indexed chromatin immunoprecipitation (co-ChIP) data
(from 8-week-old female C57BL/6 J mice) that allow the
detection of co-occurrences of H3K4me3 and H3K27me3
on the same nucleosome [61] to identify bivalent
chromatin domains. We found a significant enrich-
ment of age-related hypermethylated DMRs for bivalent
CGIs (Additional file 1: Figure S5B), with 77 DMRs map-
ping onto 64 bivalent CGIs (Additional file 9: Table S8),
exemplified by the Nol3 promoter CGI (Additional
file 1: Figure S6A). Bivalent CGIs were also enriched
among DR-ameliorated age-related DMRs, with 14
DMRs mapping onto seven bivalent CGIs (Additional
file 1: Figure S5B). Age-related hypermethylated DMRs
were also enriched for repressors, defined by H3K27me3
modifications (see “Methods” for details; Additional
file 1: Figure S5B). Notably, DR-ameliorated age-
related DMRs were different in that they were not
enriched for repressive promoter chromatin (Additional
file 1: Figure S5B). Future studies profiling chromatin
marks in DR will uncover whether this indicates chroma-
tin alterations brought about by DR or altered coupling
between DNA methylation and histone marks.
Transposable elements have been implicated in age-
related loss of genome integrity [43, 62]. However,
transposons were under-represented among hyper- and
hypomethylated DMRs (Additional file 1: Figure S7A, B).
Thus, our data do not support a major role of DNA
methylation in age-related loss of genome integrity medi-
ated by transposable elements.
Age-related differential methylation is not globally
associated with changes in gene expression
DNA methylation of promoters and gene bodies can be
associated with transcription although the links are often
context-dependent [25, 49, 56, 63, 64]. A clear associ-
ation between changes in DNA methylation and gene
expression during aging has not been reliably established
[25, 36, 65], with a possible exception of distal enhancer re-
gions in mouse beta cells [66]. Because age-related DMRs
showed a highly significant enrichment over genes (Add-
itional file 1: Figure S8A), we asked whether they were asso-
ciated with changes in gene expression in mouse liver. We
selected genes with at least two age-related DMRs mapping
to the gene body, including the transcription start site, and
plotted age-related methylation differences and respective
expression changes (Additional file 1: Figure S8B, C). We
did not detect any significant association under either AL
(Additional file 1: Figure S8B) or DR conditions (Additional
file 1: Figure S8C). Similar results were obtained when the
analysis was limited to genes that showed significant gene
expression changes with age (red data points in Additional
file 1: Figure S8B, C) and to DMRs that significantly
changed with age under DR conditions (Additional file 1:
Figure S8D, E). Hence, there is no global link between age-
related methylation and transcription dynamics. However,
in the next section we identify specific groups of genes in
which such links were modified by age and diet.
DR induces gene body methylation and associated
transcriptional changes during aging
DR can induce diet-specific gene expression programs
independent of age effects [17, 19], and we therefore
examined how DR affected DNA methylation at young
and old age. We identified 2008 and 1109 diet-induced
DMRs in young and old animals, respectively (Fig. 4a).
In young animals, 1509 were hypermethylated and 499
hypomethylated, while in old animals 914 were hyper-
methylated and 195 hypomethylated. DR therefore
predominantly caused hypermethylation at both ages
(Fig. 4a). Diet-induced methylation changes were in the
range of 10–30% (Fig. 4b), similar to the magnitude of
age-related methylation changes (compare Fig. 2d).
We identified significantly more dietary DMRs at
young age (2008) than at old age (1109) (Fig. 4a). There
was only a small subset of DMRs that were differentially
methylated in both young and old animals (highlighted
red in Additional file 1: Figure S9A), indicating that
long-term DR treatment induces methylation changes
that are different from the apparently transient changes
seen in young DR animals.
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In young animals there was weak enrichment of
DR DMRs over genic elements, including genes
(Additional file 1: Figure S9B, C), and there was no
significant correlation between differential methylation
and transcription (Additional file 1: Figure S9D, E).
Notably, however, in old animals there was a strong
Fig. 4 DNA methylation changes in the mouse liver in response to dietary restriction (DR). a Number of significantly (p < 0.05) differentially
methylated regions (DMRs) (DNA methylation difference > ±10%) between ad libitum-fed (AL) and DR at young and old age. b Density scatter
plot indicating the magnitude of DNA methylation changes between diets with respect to the methylation level of old AL animals. Lines indicate
median of methylation levels for hypo- and hypermethylated DMRs. Average DNA methylation levels were significantly different between
hypo- and hypermethylated Old-DR DMRs. *** p < 0.001, Wilcoxon-rank-sum test. c, d Enrichment analysis of hyper- (c) and hypomethylated (d)
Old-DR DMRs over genomic elements. e, f Scatterplot of expression differences versus methylation differences of Old-DR DMRs in young (e) and
old (f) animals. Dashed lines indicate DNA methylation cutoff of > ±10%. There was no significant correlation between DNA methylation and gene
expression in young animals (Fisher’s test p= 1). In contrast, DNA methylation and gene expression were significantly negatively correlated in old animals
(Fisher’s test p <0.001, Pearson correlation −0.387 for all genes; p <0.001, Pearson correlation −0.556 for differentially expressed genes). Number of
differentially methylated genes in each quadrant is indicated in blue and red, for all genes and differentially expressed genes, respectively. g Gene ontology
and reactome enrichment of genes with a negative correlation of gene expression and methylation. Lengths of bars represent negative log-transformed,
adjusted p values using Fisher’s exact enrichment test. Cells indicate log2-fold changes (log2FC) between AL and DR per gene. CGI CpG island
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enrichment of DR DMRs in the gene body (Fig. 4c, d).
Genes with DR-induced methylation differences in the
gene body were enriched for fatty acid, triglyceride and ke-
tone body metabolism-related gene ontology (GO) terms
(Additional file 1: Figure S10A; Additional file 10: Table
S9; Additional file 11: Table S10; Additional file 12: Table
S11; Additional file 13: Table S12). Intriguingly, in old ani-
mals DR also resulted in a significant negative correlation
between DNA methylation and gene repression on a lar-
ger scale (Fig. 4f). Hence, 56 genes showed an inverse rela-
tionship between gene expression and DNA methylation
(Fig. 4f; Additional file 11: Table S10). GO and Reactome
pathway analysis showed an enrichment of terms related
to lipid metabolism and energy homeostasis (Fig. 4g).
These genes code for several key enzymes of hepatic lipid
metabolism including ATP-citrate lyase (Acly), Malic en-
zyme 1 (Me1) [67], acetoacetyl-CoA synthetase (AACS2)
[68], pyruvate kinase (PKLR) [69], glycerol-3-phosphate
acyltransferase (GPAM) [70], fatty acid elongase 6 (Elovl6)
[71] and acetyl-CoA carboxylase 1 (ACACA) [72] (Fig. 4f).
Notably, these genes are all direct targets of the transcrip-
tion factors Srebf1 (also known as SREBP1) and ChREBP,
two well-known regulators of hepatic lipogenesis [67, 73,
74]. Indeed, the Srebf1 gene itself was hypermethylated and
downregulated upon DR treatment (Fig. 4f). Hence, long-
term DR-induced methylation and gene expression changes
are specifically associated with hepatic lipid homeostasis.
Interestingly, in 18 of the 56 genes, we observed methy-
lation differences, for example in the Elovl6 gene, that
stretched over both introns and exons in the entire gene
body but not the promoter region or neighboring genes
(Fig. 5a; Additional file 14: Table S13). Quantification of
whole gene body methylation by examining single bins
per gene showed that all 18 genes had a whole gene body
methylation difference of at least 2.5% between AL and
DR at old age (Fig. 5b, c). Genes with whole body methyla-
tion differences were enriched for fatty acid, triglyceride
and ketone body metabolism-related GO terms (Fig. 5d).
Many of the genes found differentially methylated
under DR in old animals were already differentially
expressed upon DR in young animals (Figs 4e and 5b).
DR-induced differential gene expression may therefore
precede gene body methylation changes, which may
serve as a long-term memory of the DR state.
While DR predominantly induced hypermethylation of
gene bodies correlated with repression, some exceptions
were also found. For example, Insulin receptor substrate 2
(IRS2) and Rassf3 showed hypomethylation (Additional
file 1: Figure S10B, C) associated with increased expres-
sion in old DR animals (Figs 4f and 5c). IRS2 is a key regu-
lator of hepatic insulin resistance and has been associated
with lifespan in mice [75]. Rassf3 is a tumor suppressor
and its expression is downregulated in several human
tumors, including liver, stomach, colon and lung cancers
[76]. Furthermore, hypermethylation of Rassf3 associated
with reduced gene expression correlates with tumori-
genesis in pituitary somatotroph adenoma [77]. The
anti-tumorigenic effect of DR may therefore include
methylation-dependent regulation of Rassf3 activity.
Long-term dietary restriction shifts the hepatic triglyceride
pool toward shorter fatty acid chain lengths
Several key enzymes of hepatic lipid metabolism were
hypermethylated and transcriptionally downregulated in
old DR animals (Fig. 4f ). These included glycerol-3-
phosphate acyltransferase, which catalyzes the first step
in glycerolipid biosynthesis [78], and ATP-citrate lyase,
which is responsible for the synthesis of cytosolic acetyl-
CoA [79], a key metabolite for the production of fatty
acids. Furthermore, fatty acid elongase 5 (Elovl5) and
Elovl6, which catalyze the initial and rate-limiting steps
in fatty-acid elongation [78–80], were also hypermethy-
lated and downregulated by long-term DR.
Because DR downregulated the expression of genes
involved in lipogenesis and fatty-acid elongation, we
probed the functional significance of these changes by
performing liquid chromatography–tandem mass spec-
trometry (LC-MS/MS) profiling of hepatic triglycerides
(TGs) from young and old animals under DR and AL
feeding. Total hepatic TG content was similar in young
AL and DR animals, but showed a larger increase with age
in AL animals, with a significant interaction between diet
and age (Fig. 6a). DR thus ameliorated the age-related
increase in hepatic TG levels. We assessed diet- and age-
related TG composition by analyzing the saturation and
chain length of TG-associated fatty acids (Fig. 6b–e).
Surprisingly, relative saturation profiles differed only at
young age, with DR animals having significantly more TGs
with four or more double bonds (Fig. 6b), an effect not seen
at old age (Fig. 6c). In contrast, DR induced a decrease in
chain length of TG-associated fatty acids both in young and
old animals (Fig. 6d, e), an effect that was already significant
in young animals and became more prominent with age. In
keeping with the observed decrease in fatty acid chain
length in old DR animals, old AL animals showed elevated
levels of TGs containing longer chain fatty acids. Hence,
consistent with hypermethylation and downregulation of
expression of key enzymes of hepatic lipid metabolism, in
particular the elongases, DR protected the liver against age-
related increase in TG content and induced a shift towards
shorter chain length in TG-associated fatty acids and TGs.
Discussion
DR extends lifespan and ameliorates many effects of aging
on organismal and specific organ physiology, but its effects
on the epigenome have not been systematically examined
[81, 82]. This is important because dietary factors can alter
epigenetic modifications and such alterations may have
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long-term consequences for gene expression and organ
function [83]. Here we have profiled DNA methylation by
whole genome BS-seq, the transcriptome and the lipidome
in female mouse liver during aging with and without DR.
Our key findings are that regions that become differentially
methylated (DMRs) during aging, either by hypo- or hyper-
methylation, experience less change during DR. However,
under DR there is a specific group of genes that acquire
gene body methylation associated with their transcriptional
repression, including key lipid regulatory genes. As a result,
the age-associated increase in liver TG content is attenu-
ated together with a reduction in TG acyl chain length.
Hence DR generally protects from age-induced methylation
changes and induces epigenetic reprogramming of lipid
metabolism genes. Therefore, physiologically meaningful
epigenetic changes occur during aging from which DR par-
tially protects and simultaneously instigates a beneficial
epigenotype.
Fig. 5 Dietary restriction (DR) caused differential whole gene body methylation of lipid metabolism genes. a Differential methylation landscape of
the Elovl6 gene locus at young and old age. Bins are represented as bars with color scale and height indicating methylation differences. Hatched
bars indicate bins that show significantly different methylation between ad libitum (AL) and DR conditions. Arrows indicate gene orientation; merged
mRNA structure is depicted below. b, c Scatterplot of differential expression versus whole gene body methylation differences at young (b) and old age
(c). Number of genes per quadrant is denoted in corners; dashed lines indicate methylation difference cutoff of > ±2.5%. Fisher’s exact test indicates a
significant (p < 0.032) inverse relationship (Pearson correlation −0.39) at old age but not at young age. d Gene ontology and reactome enrichment
of genes with an inverse relationship of whole gene body methylation and differential expression at old age. Lengths of bars represent negative log-
transformed, adjusted p values for Fisher’s exact enrichment test. Cells indicate log2-fold changes (log2FC) between AL and DR per gene
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We determined a small overall increase of CpG methy-
lation in the liver during aging, consistent with identifying
more hypermethylated than hypomethylated DMRs.
Because there is generally both a loss and a gain of methy-
lation during aging [84], the net effect on global methyla-
tion levels will likely depend on the tissue. Interestingly,
under DR there was a concurrent reduction of the de
novo methylase Dnmt3b and the dioxygenase Tet2. This
would predict lower methylation turnover [84] and hence
reduced erosion of methylation patterns over time, which
is what we observed. Given that known signaling pathways
regulate Dnmt3b (Erk1,2; Gsk3beta; [85]) and Tet2 (ret-
inol and retinoic acid; [86]), the control of these pathways
will be intricately integrated into regulated aging.
Alteration of acyl chain length and saturation of mem-
brane lipids will impact on the structure of the plasma
and other membranes, which will lead to modification of
membrane domains such as lipid rafts [87]. This in turn
will modify the activation of PI3kinase and Raf signaling
[88] upstream of Erk, GSKbeta and SREBP [89, 90]. Thus
these lipid-modifying pathways, which modulate mem-
brane fluidity, could be candidates for exploring for the
signaling effects of DR.
Age-related DMRs were predominantly found in gene
bodies, and age-related hypomethylated DMRs were as-
sociated with genes that regulate fatty acid, lipid and
acyl-CoA metabolism, among others. Although globally
there was no connection between methylation and
Fig. 6 Lipidome profiling of dietary restriction (DR)-induced changes in triglyceride (TG) acyl chain length and saturation in the mouse liver. a Hepatic
TG content of ad libitum-fed (AL) and DR animals at young and old age. There was a significant interaction between diet and age (two-way ANOVA
p < 0.05). b-e Distribution of TG species in young (b, d) and old animals (c, e) classified according to the degree of saturation (b, c) and number of
carbon atoms (d, e) as proxy for TG-associated fatty acid chain length. Values represent normalized relative abundances (0–100%) on a logarithmic
scale. Indicated are p values for pairwise comparisons for each species (Tukey range test) and for specific intervals (paired Wilcoxon-rank-sum test). DR
animals showed significantly more TGs with four or more double bonds at young age (b, p = 0.0039; paired Wilcoxon-rank-sum test) and significantly
more TGs with 52 or fewer carbons at old age (e, p = 0.0078; paired Wilcoxon-rank-sum test). AL animals showed significantly more TGs with 54 or
fewer carbons at old age (e, p = 0.052; paired Wilcoxon-rank-sum test). • p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001. Error bars denote means ± SEM.
f, g Schematic outline of differential methylation and gene expression in the Sreb1f (SREBP1) network under AL (f) and DR (g) conditions
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transcription, which is not unexpected given the many
different levels of epigenetic regulation, this signature is
also one of the major ones at the transcriptional level,
reflecting a consistent change in lipid metabolism during
aging.
Age-related methylation changes will not only be in-
fluenced by the overall tuning of the methylation and
demethylation machinery, but also by local interactions
with chromatin and transcription factors [34, 65, 91].
Indeed we found that hypomethylated DMRs were gen-
erally enriched for open chromatin marks and transcrip-
tion factor binding sites, while hypermethylated DMRs
were more enriched for heterochromatic marks, reflect-
ing established relationships with the DNA methylation
machinery [34, 36, 91, 92]. At this point, however, this
analysis is imperfect because histone mark profiling data
are only available from young male animals; they may
well change during aging or in a sex-specific manner,
too. For example, hypermethylated age-related DMRs
were enriched for repressive promoter chromatin char-
acterized by the repressive mark H3K27me3. In contrast,
DR-ameliorated DMRs, which no longer become hyper-
methylated during aging under DR, were not enriched
for repressive promoter chromatin. This indicates the
possibility that the H3K27me3 mark in these regions
may become altered during aging. In our study we used
liver samples from three female mice per treatment
group, consistent with accepted guidelines for tran-
scriptomics and DNA methylation studies [93–95]. Fu-
ture work should extend our findings to male animals
and other genotypes.
We identified a specific subset of 18 genes that showed
DR-induced differential methylation spanning large parts of
the gene body. DNA methylation in gene bodies has been
proposed to function in the regulation of alternative spli-
cing, silencing of alternative promoters or the regulation of
other functional elements [96–98]. However, the differential
whole gene body methylation detected here was relatively
evenly distributed over the whole gene body and not as-
sociated with specific gene features like exons, introns
or promoter elements, suggesting a different function.
Whole gene body methylation might slow down tran-
scription elongation rates [99, 100] and thereby con-
tribute to the inverse relationship of gene expression
and DNA methylation observed in these genes.
DR causes reduced hepatic lipogenesis and increased
utilization of lipids as an energy source via enhanced
lipolysis [101]. It thereby protects aged animals from
steatosis and visceral fat accumulation [23], accompan-
ied by the amelioration of age-dependent insulin resist-
ance [101]. The transcription factor Srebf1 (SREBP1) is
a key regulator of lipogenic enzyme expression in the
liver [67, 73, 74] and mediates hepatic insulin resistance
through inhibition of IRS-2 [102]. Interestingly, we
found that the Srebf1 gene itself and key Srebf1 target
genes like Acly, Me1 [67], AACS [68], ACACA [72],
GPAM [70], and Elovl5 [103] and Elovl6 [71], which
catalyze rate-limiting steps in fatty acid synthesis and
fatty acid elongation [104], respectively, were hyper-
methylated and transcriptionally downregulated in
response to DR (Fig. 6f, g). Consistent with our data,
downregulation of Srebf1 has been suggested to play an
important role in gene regulation upon DR in rodents
[18]. Furthermore, DR caused hypomethylation of the
IRS-2 gene and increased IRS-2 expression. IRS-2 is a
direct Srebf1 target gene and is upregulated during
nutrient deprivation in the liver via the Foxo1 tran-
scription factor. Under AL-fed conditions, Srebf1 inter-
feres with the binding of Foxo1 to the IRS-2 promoter
and thereby represses IRS-2 expression [102]. Loss of IRS-
2 function results in hepatic insulin resistance [105], an
important pathophysiological feature of age-related type 2
diabetes. In summary, our data suggest epigenetic regula-
tion of the Srebf1 network as an integral mechanism by
which DR protects organisms against age-related steatosis
and hepatic insulin resistance.
Consistent with hypermethylation and transcriptional
downregulation of fatty acid elongases under DR, we
observed a shift in the hepatic triglyceride pool toward
medium-chain triglycerides (MCTs). Dietary supplementa-
tion of MCTs has been shown to prevent diet-induced liver
pathologies and insulin resistance and is used in the treat-
ment of refractory childhood epilepsy [106–108]. Interest-
ingly, DR treatment has been shown to reduce seizures in
rodent epilepsy models [109, 110]; however, whether MCTs
are involved in the beneficial effects of DR is currently un-
known and could be explored in future studies. The age-
related shift in acyl chain length will additionally reduce the
energy metabolic capability of the cells and can have further
functional consequences, such as different fatty acid species
being generated through ATGL-catalyzed TG hydrolysis,
which could for example have distinct PPARα-activating
capacity [111]. Further, an increase in saturated TGs will in-
crease saturated diaglycerides that have been shown to de-
crease insulin sensitivity with a consequent promotion of
obesity [112]. Conversely, the DR-induced change in lipid
elongases and other enzymes will positively regulate insulin
sensitivity, a key event in healthy aging. Notably this will
parallel the increase in IRS-2 expression, which will further
increase insulin signaling, improving the metabolic health
of animals during aging.
Conclusions
This study provides novel insights into the effect of dietary
restriction (DR) on age-related DNA methylation. DR
caused remodeling of genome-wide patterns of DNA
methylation so that age-related changes were delayed,
while changes at specific loci involved in lipid metabolism
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affected gene expression and the resulting lipid profile.
Our work has therefore uncovered an epigenetic axis that
links the long-term beneficial effects of DR with specific
transcriptional and functional outcomes on metabolism.
Methods
Animals and DR protocol
The DR study was performed in accordance with the
recommendations and guideline of the Federation of the
European Laboratory Animal Science Association
(FELASA), with all protocols approved by the Landesamt
für Natur, Umwelt und Verbraucherschutz, Nordrhein-
Westfalen, Germany. Animals used in this study were
female F1 hybrid mice (C3B6F1) generated by mating
C3H/HeOuJ females with C57BL/6 N males. Parental
animals were received from Charles River Laboratories
(Lyon, France) and breeding of experimental animals was
done in the in-house animal facility. Litter size was ad-
justed to a maximum of eight pups by culling surplus male
pups within 3 days of birth and animals were weaned at
21–28 days of age. Animals were housed in groups of five
in individually ventilated cages under specific-pathogen-
free conditions with constant temperature (21 °C) and hu-
midity (50–60%) and a 12-hour light/dark cycle. All mice
were fed commercial rodent chow (ssniff R/M-H autocla-
vable, ssniff Spezialdiäten GmbH, Soest, Germany) and
were provided with acidified water ad libitum. The
food uptake of AL-fed animals was measured weekly
and DR was applied by feeding DR animals 40% less
food. Adult-onset DR treatment was started at the
age of 12 weeks in a stepwise manner, by reducing
food amounts fed to DR animals by 10% each week
until the 40% reduction was reached. DR animals
were fed once a day and all animals were checked
daily for their well being and any deaths.
Tissue sample collection
At the age of 5 and 27 months, which corresponded to 2
and 24 months of DR treatment, respectively, mice were
killed by cervical dislocation and organs were immediately
harvested and flash-frozen. On the day they were killed,
tissue samples were collected in a 3 h time-window in the
morning prior to the regular feeding of DR mice.
RNA-seq measurement and analysis
RNA from three AL and three DR animals per time
point was isolated from 30 mg of liver tissue using
Trizol Reagent (Thermo Fisher Scientific, Darmstadt,
Germany) according to the manufacturer’s instructions,
followed by DNAse treatment with the TURBO DNA-
free Kit (Thermo Fisher Scientific). RNA integrity was
analyzed using the Agilent TapeStation System (Agilent
Technologies, Frankfurt, Germany). RNA-seq library
preparation and sequencing was performed by the
Max Planck-Genome-centre Cologne, Germany
(http://mpgc.mpipz.mpg.de/home/). Stranded TruSeq
RNA-seq library preparation was conducted as previ-
ously described [113] using 3 μg of total RNA as in-
put and rRNA depletion. Barcoded libraries were
sequenced with 2 × 40 mio, 100 bp paired-end reads on an
Illumina HiSeq2500 (Illumina, San Diego, California,
USA). Raw sequence reads were trimmed to remove
adaptor contamination and poor-quality reads using Trim
Galore! (v0.3.7, parameters: –paired –length 25). A modi-
fied mouse reference genome (build GRCm38), with all
known single nucleotide polymorphisms replaced by ‘N’
was set up to account for the hybrid genome of the
C3B6F1 mice. Trimmed sequences were aligned using
Tophat2 [114] (v2.0.14, parameters: –no-mixed –library-
type = fr-firststrand -g 2 -p 15 -r 500 –mate-std-dev 525),
supplying GENCODE annotation [115] (release M9, main
annotation) for improved mapping. Multi-mapped reads
were filtered using samtools [116] (v1.2, parameters:
view -F 0x100 -b –h). Data visualization and analysis
was performed using SeqMonk, ClueGO [117] custom
RStudio and the following Bioconductor packages: Deseq2
[118], topGO [119], org.Mm.eg.db. For Figs. 4g and 5d, we
further used the CellPlot package (https://github.com/
dieterich-lab/CellPlot). To account for tissue-specific
expression, we defined all genes passing the independent
filtering of Deseq2 [118] as “expressed” (13,649 genes in
total). DEGs were determined using Deseq2’s Wald test
[118] run across all four treatment groups (age and diet),
with subsequent pair-wise contrasts. p values were
adjusted for multiple testing. Genes were considered
to be significantly differentially expressed with a an
adjusted p value <0.05 and no cutoff for fold change was
used. Unless stated otherwise, the set of expressed genes
was used as background for all functional enrichment
analyses involving expression data.
cDNA synthesis and qRT-PCR
For qRT-PCR validation of gene expression changes,
RNA was isolated from an independent set of three AL
and three DR animals per time point. RNA isolation was
done as described for the RNA-seq experiment. cDNA
was synthesized from 5 μg of RNA using SuperScript
VILO Master Mix (Thermo Fisher Scientific) according
to the manufacturer’s instructions. qRT-PCR was per-
formed using TaqMan Gene Expression Assays (Thermo
Fisher Scientific) in combination with TaqMan Gene
Expression Master Mix according to the manufacturer’s
instructions. Liquid handling was done with a Janus
Automated Workstation (PerkinElmer, Waltham, Massa-
chusetts, USA) and cycling was carried out on a 7900HT
Fast Real-Time PCR System (Thermo Fisher Scientific).
Relative expression was calculated using the ΔΔCT
method and Polr2i as normalization control. The
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following TaqMan gene expression assays were used:
Pnpla3 (Mm00504420_m1), Fasn (Mm00662319_m1),
Irs2 (Mm03038438_m1), Cyp3a11 (Mm00731567_m1),
Tet3 (Mm00805756_m1), Gna14 (Mm00492374_m1),
GNMT (Mm00494688_m1) and Polr2i (Mm01
176661_g1).
BS-seq measurement and differential methylation analysis
DNA of three AL and three DR animals per time point
was isolated from 30 mg of liver tissue using the AllPrep
DNA/RNA Mini Kit (Qiagen, Hilden, Germany) accord-
ing to the manufacturer’s instructions. Around 400 ng of
genomic DNA was used as input for BS-Seq library
generation. DNA was sonicated, and end repair and A-
tailing were performed using the NEBNext kit according
to the manufacturer’s instructions (New England
Biolabs, Frankfurt, Germany). Illumina’s Early Access
Methylation Adaptor Oligo Kit was used for adaptor
ligation. As described previously [120], adaptor-ligated
DNA was treated with sodium-bisulfite using the
Imprint DNA Modification Kit (Sigma-Aldrich, Munich,
Germany) according to the manufacturer’s instructions
for the one-step protocol. Bisulfite-treated DNA was
amplified using PfuTurbo Cx Hotstart DNA Polymerase
from Agilent Technologies with 14–18 cycles depending
on input amount. Size selection was performed by gel
extraction for DNA fragments between 200 bp and
250 bp. Libraries of young samples were sequenced
using the paired-end protocol. Old sample libraries were
sequenced using a single-end protocol and a subsequent
re-run using a paired-end protocol to increase coverage.
The data have been deposited in NCBI’s Gene Expres-
sion Omnibus [121] and are accessible through [GEO:
GSE92486].
Raw sequence reads were trimmed using Trim Galore!
(v0.4.2). Trimmed sequences were aligned using Bismark
[122] (v0.16.3). Methylation calls were extracted after du-
plicate sequences had been excluded. Data visualization
and analysis were performed using SeqMonk and custom
RStudio scripts. Data from replicates of the same condi-
tion were merged using SeqMonk’s data group option, in
order to enhance coverage and detection of subtle differ-
ences. However, we verified that the regions we identified
as differentially methylated with age or DR were con-
sistently regulated among replicates and not a result
of strong methylation differences in single samples
(Additional file 1: Figure S11A–D). Regions with an
unusually high number of observations were detected
and filtered using non-overlapping 25 kb windows,
followed by read count quantification and subsequent
BoxWhisker filter implemented in SeqMonk with
stringency >10. To try to achieve a fair and unbiased
analysis of the methylome, we constructed windows
containing 50 CpGs over the whole genome, spaced
25 CpGs apart. Each window therefore contained
around the same amount of data and all windows had
similar technical noise and statistical power. Further-
more, to reduce the effect of coverage differences
between samples, only cytosines covered by at least
three observations in all conditions were used in the
differential methylation analysis. Methylation for each
window was calculated as the average of methylation
for each covered CpG position. Windows that contained
significantly different methylation levels (pairwise Chi-
squared tests with subsequent multiple testing correction;
adjusted p value <0.05) and a minimal difference cutoff of
10% were defined as differentially methylated (DMR).
Compter (http://www.bioinformatics.babraham.ac.uk/pro
jects/compter/) analysis was used to show that DMRs had
no composition bias in their underlying sequence. Hypo-
and hypermethylated DMRs showed the same se-
quence composition (data not shown). We defined
three sets of DMRs: (1) age-related DMRs: DMRs
showing a significant change under AL with age, that
is, ALyoung versus ALold; (2) Young-DR DMRs: show-
ing significant change between ALyoung and DRyoung;
and (3) Old-DR DMRs: showing significant change be-
tween ALold and DRold. For the example in Additional file
1: Figure S6A, the methylation landscape over bivalent
CGI of Nol3 was visualized by calculating average CpG
methylation levels of 500 bp 250 bp overlapping bins to
improve resolution.
Profiling of ameliorated age-related methylation changes
under DR
For each bin, we calculated differences between the diets
after aging occurred, that is, at old age (DRold versus
ALold), and plotted these against differences during aging
under either AL or DR conditions (ALold versus ALyoung;
DRold versus DRyoung). We next performed linear regres-
sion and calculated the Pearson correlation coefficient
for differences at old age between diets as a function of
age-related differences under AL or DR. The observed
slope of the linear fits and correlation coefficients were
compared to permutation studies to confirm the robust-
ness of our findings. Therefore, we permutated the treat-
ment labels per bin and calculated correlation and slope
as before, which resembles a relationship based on noise
only. We repeated the permutations, randomizing treat-
ment labels for ALyoung with ALold and DRyoung with
DRold (“across age, within same diet”) to exclude general
effects between the diets. Finally, we also randomized
ALyoung with DRyoung and ALold with DRold (“across di-
ets, within same age”), thereby averaging out differences
between diets, focusing on general differences between
young and old.
We next analyzed age-related DMRs scattering strongly
from the linear fit under DR conditions (Fig. 3a, b),
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because these represent age-related effects ameliorated by
DR. We used two standard deviations (2*σ; corresponding
to ±9.68% methylation difference) of the distribution of
residuals for aging under AL conditions as an estimate of
naturally random scattering. We then determined which
age-related DMRs scattered beyond this cutoff from the
linear fit for aging under DR conditions. These were
defined as DR-ameliorated age-related DMRs.
Enrichment analyses of DMRs over genomic and
epigenetic elements
For a given genomic element, we calculated the enrichment
for a set of DMRs by counting the number of DMRs over-
lapping the element of interest and compared it to the set
of background bins (whole genome; n = 1,167,959). One-
sided Fisher’s exact test with subsequent multiple testing
correction (if enrichment analysis was run over multiple
elements) was performed to determine the statistical sig-
nificance of enrichment. Because most elements showed
highly significant enrichment, we –log-transformed the ad-
justed p values. The ratio of the observed DMR frequency
and the average frequency across the genome (“observed/
expected”) for individual elements were used to compare
enrichments across elements and between DMR sets. This
way we were able compare the strengths of enrichments
across elements in the same analysis.
Functional enrichment analyses of differentially
methylated genes
Unless stated otherwise, we performed functional en-
richment of genes overlapped by a defined number of
DMRs using topGO [119] with all genes in the genome
as background.
coChIP-seq analysis
coChIP allows the co-occurrence of two histone modifica-
tions on the same nucleosome to be detected. We there-
fore retrieved previously published coChIP-seq data [61]
from the Gene Expression Omnibus repository and re-
analyzed them. The analyzed data measured coChIP
against H3K4me3-H3K27me3 in 8–12-week-old female
C57BL/6 J mice in two biological replicates. Raw sequence
reads were trimmed to remove adaptor contamination
and poor-quality reads using Trim Galore! (v0.3.7, param-
eters: –paired –length 20). Trimmed sequences were
aligned using Bowtie2 [123] (v2.0.14, default parameters).
The resulting files were merged and multi-mapped reads
discarded using samtools [116] (v1.2, parameters: view -F
0x100 -b –h). Peak calling was performed using MACS2
[124] (v2.1.1, parameters: callpeak -g hs –n test –B –q
0.01). Data visualization and mapping to CGIs was per-
formed using SeqMonk and custom RStudio.
Identification of whole gene body methylation
To identify genes that showed consistent differential
methylation across their gene body, we tested each gene
for significant enrichment of overlapping DMRs com-
pared to all bins overlapping. A minimum of four over-
lapping bins was required. p values from Fisher’s exact
test were corrected for multiple testing (Benjamini-
Hochberg). Methylation of genes with a p value <0.05
was quantitated using all CpGs within the gene body
and a minimal difference of ±2.5% was set as cutoff.
Correlation analysis of methylation and transcription
To test for correlation between differential methylation
and gene expression, we considered only genes overlapped
by at least two DMRs. We averaged methylation differ-
ences for multiple DMRs overlapping the same gene
before plotting, and only retained those showing at least
10% average difference. We thereby avoided unclear cases
with an equal extent of hyper- and hypomethylation
occurring over the same gene. We plotted log2-fold
expression changes versus methylation differences, and
the distribution of genes among the four resulting
quadrants was tested for directionality using Fisher’s exact
test. We additionally calculated a Pearson correlation esti-
mate for all genes above the 10% (2.5% for whole body
gene methylation) methylation cutoff. Genes that showed
a significant correlation of methylation and gene expres-
sion were analyzed for functional enrichment using
topGO [119].
Triglyceride lipidome measurement and analysis
Extraction, measurement and quantification of lipids
was performed as previously described [125], with
800 ng of synthetic 17:1/17:1/17:1-TG standard. We
analyzed liver tissue from four young AL and four young
DR mice, as well as three old AL and three old DR mice.
We analyzed TG content using two-way ANOVA to test
for an interaction between the factors age (young, old)
and diet (AL, DR). Individual lipid species were calcu-
lated as the percent of the entire TG lipidome. For
elongation and saturation analysis, TG species with the
same number of carbons/double bonds were calculated
as a percentage of the entire TG lipidome. We con-
ducted one-way ANOVA with post-hoc Tukey HSD for
each chain length/saturation to test for significant differ-
ences. In order to test whether the DR-induced shift to-
wards shorter TG acyl chain composition was significant
(Fig. 6), we averaged replicates of the same condition for
each chain length and ran a pairwise Wilcoxon rank-
sum test across the left (38:x to 52:x) and right tail of
the chain length plot (54:x to 60:x). A saturation analysis
was run accordingly, analyzing the interval from 0–3
and 4–12 double bonds.
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Definition of genomic and epigenetic elements
Gene annotation used in this study was obtained from
the UCSC Genome Browser database [126]. We defined
further genome annotation as follows:
Promoter region: Manually defined region stretching
from 5 kbp upstream and 100 bp downstream of the
transcription start site.
CGI: Annotation based on CXXC affinity purification
plus deep sequencing (CAP-seq) experiments [127].
CGIs were further classified unambiguously into pro-
moter, gene and intergenic CGIs. If a CGI overlapped
both promoter and gene body, it was classified as a pro-
moter CGI.
Repetitive elements: Annotation based on Repbase
[128] and obtained via the UCSC Table Browser [129].
Histone modification ChIP-seq peaks: Publicly
available, pre-processed H3K9ac, H3K4me1, H3K27ac,
H3K4me3, H3K79me2, H3K27me3 and H3K36 ChIP-
seq peaks from liver tissue of 8-week-old male C57BL/6
mice were obtained from the ENCODE dataset [57] and
re-mapped to the GRCm38 genome using UCSC Genome
Browser’s LiftOver [130].
Active enhancer: H3K4me1 mark overlapping the
H3K27ac mark; further classified into geneic (overlapping
gene or promoter) and distal.
Active promoter chromatin: H3K4me3 mark overlap-
ping the H3K9 mark within 100 bp, without overlapping
the H3K27me3 mark within 100 bp distance. Further
overlapping the promoter region.
Repressive promoter chromatin: Narrow H3K27me3
mark (smaller than 3.5 kbp) that did not overlap
H3K27ac or H3K4me3 within 100 bp distance. Overlap-
ping the promoter region.
Repressive geneic chromatin: H3K27me3 mark that
did not overlap H3K27ac or H3K4me3 within 100 bp dis-
tance. Overlapping the gene body. Where the repressive
mark overlapped promoter and gene, it was classified as a
promoter mark.
Bivalent CGI: CGI overlapped by one or more
coChIP-seq peaks (against H3K4me3-H3K27me3). We
did not differentiate between promoter or gene body
CGIs. For annotation and enrichment analyses, bivalent
CGIs were also counted when a DMR mapped to the
CGI but did not overlap the H3K4me3-H3K27me3 peak.
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